Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.059 | 0.7 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |